42 related articles for article (PubMed ID: 19921530)
1. Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer.
Barquet-Muñoz SA; Rendón-Pereira GJ; Acuña-González D; Peñate MV; Herrera-Montalvo LA; Gallardo-Alvarado LN; Cantú-de León DF; Pareja R
World J Surg Oncol; 2017 Jan; 15(1):23. PubMed ID: 28088221
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Carcinosarcoma with Retroperitoneal Para-Aortic Lymph Node Dissemination Followed by an Unusual Postoperative Complication: A Case Report with a Brief Literature Review.
Kostov S; Kornovski Y; Ivanova Y; Dzhenkov D; Stoyanov G; Stoilov S; Slavchev S; Trendafilova E; Yordanov A
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322259
[No Abstract] [Full Text] [Related]
3. Outcome analysis in patients with uterine sarcoma.
Yu T; Kim HJ; Wu HG; Ha SW; Song YS; Park NH; Kim JW
Radiat Oncol J; 2015 Mar; 33(1):29-35. PubMed ID: 25874175
[TBL] [Abstract][Full Text] [Related]
4. Radical abdomino-pelvic surgery in the management of uterine carcinosarcoma with concomitant para-aortic lymphadenopathy metastasising from anal carcinoma.
Cowdell I; Smyth SL; Eltawab S; Soleymani Majd H
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36450419
[TBL] [Abstract][Full Text] [Related]
5. Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status.
da Silva JL; de Albuquerque LZ; Rodrigues FR; Bastos NC; Small IA; Barroso EBC; Cordero FL; Fernandes DS; Paulino E; de Melo AC
PLoS One; 2023; 18(5):e0285447. PubMed ID: 37200263
[TBL] [Abstract][Full Text] [Related]
6. A Study of Prognostic Factors of Chinese Patients with Gynecologic Tract Carcinosarcomas Prognosis of Gynecologic Carcinosarcomas.
Ye D; Shen HR; Yao L
Cancer Manag Res; 2020; 12():10781-10788. PubMed ID: 33149683
[TBL] [Abstract][Full Text] [Related]
7. Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study.
Kimyon Cömert G; Türkmen O; Boyraz G; Yalçın İ; Altın D; Karalök A; Şahin H; Taşkın S; Başaran D; Fırat Cuylan Z; Koyuncu K; Salman MC; Özgül N; Meydanlı MM; Turan T; Ortaç F; Yüce K
Balkan Med J; 2019 Jul; 36(4):229-234. PubMed ID: 30873825
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
[TBL] [Abstract][Full Text] [Related]
9. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).
Denschlag D; Thiel FC; Ackermann S; Harter P; Juhasz-Boess I; Mallmann P; Strauss HG; Ulrich U; Horn LC; Schmidt D; Vordermark D; Vogl T; Reichardt P; Gaß P; Gebhardt M; Beckmann MW
Geburtshilfe Frauenheilkd; 2015 Oct; 75(10):1028-1042. PubMed ID: 26640293
[No Abstract] [Full Text] [Related]
10. Review of Recommended Treatment of Uterine Carcinosarcoma.
Menczer J
Curr Treat Options Oncol; 2015 Nov; 16(11):53. PubMed ID: 26374341
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
Int J Clin Oncol; 2016 Feb; 21(1):168-76. PubMed ID: 26084780
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant treatment modalities, prognostic predictors and outcomes of uterine carcinosarcomas.
Gungorduk K; Ozdemir A; Ertas IE; Gokcu M; Telli E; Oge T; Sahbaz A; Sayhan S; Sanci M; Harma M; Ozalp S
Cancer Res Treat; 2015 Apr; 47(2):282-9. PubMed ID: 25358384
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of postoperative chemotherapy in patients with uterine carcinosarcoma: a retrospective survey of the Tohoku Gynecologic Cancer Unit.
Otsuki A; Otsuki T; Tokunaga H; Niikura H; Nagase S; Sugiyama T; Toyoshima M; Utsunomiya H; Yokoyama Y; Mizunuma H; Sato N; Terada Y; Shoji T; Sugiyama T; Nakahara K; Ohta T; Yamada H; Tase T; Nishiyama H; Fujimori K; Takano T; Takahashi F; Watanabe Y; Yaegashi N
Int J Clin Oncol; 2015 Jun; 20(3):574-8. PubMed ID: 25030547
[TBL] [Abstract][Full Text] [Related]
14. A cohort study evaluating paraaortic lymphadenectomy in endometrial cancer.
Zhang H; Zuo Z; Wang Y; Wang L; Zhu Z
Oncol Lett; 2012 Dec; 4(6):1361-1365. PubMed ID: 23205136
[TBL] [Abstract][Full Text] [Related]
15. The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Ann Surg Oncol; 2010 Mar; 17(3):861-8. PubMed ID: 19921530
[TBL] [Abstract][Full Text] [Related]
16. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
17. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
Lea JS; Sheets EE; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Feb; 84(2):285-8. PubMed ID: 11812088
[TBL] [Abstract][Full Text] [Related]
18. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
Delpech Y; Haie-Meder C; Rey A; Zafrani Y; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
Ann Surg Oncol; 2007 Nov; 14(11):3223-31. PubMed ID: 17713822
[TBL] [Abstract][Full Text] [Related]
19. Management of lymph nodes in endometrioid uterine cancer.
Delpech Y; Barranger E
Curr Opin Oncol; 2010 Sep; 22(5):487-91. PubMed ID: 20531186
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
